Business Wire

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Nasdaq

Quidel Receives Emergency Authorization for First Rapid Antigen “ABC Test”: A Combination Diagnostic Assay for Influenza A+B and COVID-19

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
Yahoo

FDA grants emergency use authorization to Quidel for first antigen test for COVID-19

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp ...
San Diego Union-Tribune

Rapid COVID-19 test propels Quidel Corp.’s revenue to new highs

San Diego’s Quidel Corp. said its third- and fourth-quarter revenue will be significantly higher than Wall Street analysts’ forecasts on the strength of its 15-minute diagnostic test for COVID-19.
Nasdaq

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

Easy-to-use test that provides results in 15 minutes is now available without a prescription The Sofia® SARS Antigen FIA shows excellent performance within the first five days of the onset of symptoms ...
Business Wire

Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing

Broadscale application of our Sofia® rapid antigen test for COVID-19 screening will catch asymptomatic cases early and limit virus spread.” The Sofia® SARS Antigen FIA is only for use under the Food ...